|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/196 | |
| A61P 3/06 |
| (11) | Patento numeris | 2736505 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12820828.7 |
| Europos patento paraiškos padavimo data | 2012-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-06-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SE2012/050835 |
| Data | 2012-07-13 |
| (87) | Numeris | WO 2013/019156 |
| Data | 2013-02-07 |
| (30) | Numeris | Data | Šalis |
| 1150728 | 2011-07-29 | SE |
| (72) |
KETELHUTH, Daniel, SE
|
| (73) |
Hansson, Göran K.,
St. Eriksgatan 14, 112 39 Stockholm,
SE
|
| (54) | 3-HYDROXYANTHRANILIC ACID (3-HAA) THERAPY FOR PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND ITS CARDIOVASCULAR COMPLICATIONS |
| 3-HYDROXYANTHRANILIC ACID (3-HAA) THERAPY FOR PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND ITS CARDIOVASCULAR COMPLICATIONS |